Back to top

Celldex Shareholders Approve Expanded Equity Incentive Plan

An update from Celldex ( ($CLDX) ) is now available. At its June 25, 2026 annual meeting, Celldex Therapeutics stockholders approved an amendment t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Celldex Therapeutics, Inc. (CLDX)